As of 2024-07-27, the Intrinsic Value of Rexnord Corp (RXN) is
62.61 USD. This RXN valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 64.92 USD, the upside of Rexnord Corp is
%.
The range of the Intrinsic Value is 41.57 - 121.14 USD
62.61 USD
Intrinsic Value
RXN Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
41.57 - 121.14 |
62.61 |
-3.6% |
| DCF (Growth 10y) |
58.30 - 158.53 |
84.99 |
30.9% |
| DCF (EBITDA 5y) |
46.67 - 64.59 |
53.89 |
-17.0% |
| DCF (EBITDA 10y) |
63.12 - 91.59 |
74.75 |
15.1% |
| Fair Value |
9.09 - 9.09 |
9.09 |
-85.99% |
| P/E |
41.25 - 49.38 |
43.64 |
-32.8% |
| EV/EBITDA |
34.50 - 46.38 |
38.75 |
-40.3% |
| EPV |
17.68 - 25.73 |
21.70 |
-66.6% |
| DDM - Stable |
14.87 - 48.35 |
31.61 |
-51.3% |
| DDM - Multi |
32.41 - 81.37 |
46.30 |
-28.7% |
RXN Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
7,863.37 |
| Beta |
1.40 |
| Outstanding shares (mil) |
121.12 |
| Enterprise Value (mil) |
8,664.57 |
| Market risk premium |
4.24% |
| Cost of Equity |
9.58% |
| Cost of Debt |
4.33% |
| WACC |
8.76% |